Upgrade to SI Premium - Free Trial

4D Molecular Therapeutics Inc. (FDMT)

14.97 +0.27 (1.84%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 4 4D Molecular Therapeutic For: Aug 19 Filed by: Kirn David August 21, 2026 4:07 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Kirn David August 19, 2026 6:29 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Aug 13 Filed by: Bizily Scott August 17, 2026 5:34 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Bizily Scott August 17, 2026 4:47 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT) August 14, 2026 6:50 AM - StreetInsider 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c August 13, 2026 4:40 PM - StreetInsider Form 144 4D Molecular Therapeutic Filed by: Bizily Scott August 13, 2026 4:35 PM - SEC Filing Form 10-Q 4D Molecular Therapeutic For: Jun 30 August 13, 2026 4:12 PM - SEC Filing Form 8-K 4D Molecular Therapeutic For: Aug 13 August 13, 2026 4:09 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Aug 04 Filed by: Kirn David August 5, 2026 4:14 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Kirn David August 4, 2026 6:09 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Aug 03 Filed by: Kirn David August 4, 2026 4:45 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Kirn David August 3, 2026 5:30 PM - SEC Filing B.Riley Starts 4D Molecular Therapeutics (FDMT) at Buy July 31, 2026 3:20 AM - StreetInsider Form 8-K 4D Molecular Therapeutic For: Jul 18 July 20, 2026 8:30 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT) July 20, 2026 6:51 AM - StreetInsider Form 4 4D Molecular Therapeutic For: Jul 09 Filed by: Kirn David July 14, 2026 5:05 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Kirn David July 10, 2026 4:55 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Kirn David July 9, 2026 5:22 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 30 Filed by: Bizily Scott July 2, 2026 4:08 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Bizily Scott June 30, 2026 4:39 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT) June 30, 2026 6:44 AM - StreetInsider Form 8-K 4D Molecular Therapeutic For: Jun 24 June 29, 2026 8:05 AM - SEC Filing 4DMT secures $200M credit facility with Hercules Capital June 29, 2026 8:00 AM - StreetInsider Vivani Medical adds August Moretti to board as Dean Baker retires June 26, 2026 7:30 AM - StreetInsider Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker June 26, 2026 7:30 AM - Globe NewsWire Form 4 4D Molecular Therapeutic For: Jun 23 Filed by: Bizily Scott June 25, 2026 4:39 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Bizily Scott June 23, 2026 4:30 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 22 Filed by: Kirn David June 23, 2026 4:19 PM - SEC Filing Form 144 4D Molecular Therapeutic Filed by: Kirn David June 22, 2026 5:58 PM - SEC Filing Form 8-K 4D Molecular Therapeutic For: Jun 17 June 22, 2026 4:21 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: Tomasello Shawn June 18, 2026 5:43 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: THEUER CHARLES June 18, 2026 5:41 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: Miller-Rich Nancy June 18, 2026 5:40 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: GRAY SUSANNAH June 18, 2026 5:39 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: MILLIGAN JOHN F June 18, 2026 5:33 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: SBLENDORIO GLENN June 18, 2026 5:30 PM - SEC Filing Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: Chacko Jacob June 18, 2026 5:29 PM - SEC Filing Full Article List